Public Comment and Testimony

Public Comment Before the FDA On In-Home HIV Testing

May 15, 2012

"One of our primary missions is  to reduce the number of new HIV infections...That is why we support approval of the OraQuick In-Home HIV Test."

Comment Before the FDA on the Use of Truvada as PrEP

May 10, 2012

"Truvada as PrEP introduces an important tool to address the HIV/AIDS epidemic in the United States."

TAI Public Comment to CDC/HRSA Advisory Committee on HIV, Hepatitis, and STD Prevention/treatment

November 16, 2011

A small ongoing work group should be formed composed of outside partners and HRSA/AIDS Bureau staff to work together to ensure health reform implementation goes as smoothly as possible for people with HIV.

TAI Public Comment to FDA Offers Strong Support for Renewal of the Prescription Drug User Fee Act

October 24, 2011

The AIDS Institute offers its strong support for the proposed recommendations of the fifth renewal of the Prescription Drug User Fee Act (PDUFA), as negotiated between the Federal Drug Administration (FDA) and the pharmaceutical industry.

Syndicate content